Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

High frequency of coexpression of maspin with p63 and p53 in squamous cell carcinoma but not in adenocarcinoma of the lung.

Choy B, Findeis-Hosey JJ, Li F, McMahon LA, Yang Q, Xu H.

Int J Clin Exp Pathol. 2013 Oct 15;6(11):2542-7.

2.

Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.

Hirai K, Koizumi K, Haraguchi S, Hirata T, Mikami I, Fukushima M, Yamagishi S, Kawashima T, Okada D, Shimizu K, Kawamoto M.

Ann Thorac Surg. 2005 Jan;79(1):248-53.

PMID:
15620951
3.

Expression of p63, TTF-1 and Maspin in Non-Small Cell Lung Carcinoma and Their Effect on the Prognosis and Differential Diagnosis.

Yaman B, Nart D, Ekren PK, Çok G, Veral A.

Turk Patoloji Derg. 2015;31(3):163-74. doi: 10.5146/tjpath.2015.01305.

4.
5.
6.

Maspin, VEGF and p53 expression in small biopsies of primary advanced lung cancer and relationship with clinicopathologic parameters.

Bircan A, Bircan S, Kapucuoglu N, Songur N, Ozturk O, Akkaya A.

Pathol Oncol Res. 2010 Dec;16(4):553-61. doi: 10.1007/s12253-010-9259-5.

PMID:
20349288
7.
8.

Prognostic significance of p53 protein and X-ray repair cross-complementing protein 1 in non-small cell lung cancer.

Rybárová S, Hodorová I, Muri J, Mihalik J, Adamkov M, Svajdler M, Piovarci D, Mirossay L.

Tumori. 2011 Jan-Feb;97(1):79-85.

9.
10.

TAp63gamma can substitute for p53 in inducing expression of the maspin tumor suppressor.

Spiesbach K, Tannapfel A, Mössner J, Engeland K.

Int J Cancer. 2005 Apr 20;114(4):555-62.

11.

Expressions of Thyroid Transcription Factor-1, Napsin A, p40, p63, CK5/6 and Desmocollin-3 in Non-Small Cell Lung Cancer, as Revealed by Imprint Cytology Using a Malinol-Based Cell-Transfer Technique.

Kawai T, Tominaga S, Hiroi S, Kameda K, Ogata S, Nakashima H, Ozeki Y, Nakanishi K.

Acta Cytol. 2015;59(6):457-64. doi: 10.1159/000442659.

PMID:
26696549
12.

Maspin, p53, p63, and Ki-67 in epithelial lesions of the tongue: from hyperplasia through dysplasia to carcinoma.

Vered M, Allon I, Dayan D.

J Oral Pathol Med. 2009 Mar;38(3):314-20. doi: 10.1111/j.1600-0714.2008.00698.x.

PMID:
18783348
13.

Reevaluation and reclassification of resected lung carcinomas originally diagnosed as squamous cell carcinoma using immunohistochemical analysis.

Kadota K, Nitadori J, Rekhtman N, Jones DR, Adusumilli PS, Travis WD.

Am J Surg Pathol. 2015 Sep;39(9):1170-80. doi: 10.1097/PAS.0000000000000439.

14.

Clinical usefulness of D2-40 in non-small cell lung cancer.

Min KH, Park SJ, Lee KS, Hwang SH, Kim SR, Moon H, Han HJ, Chung MJ, Lee YC.

Lung. 2011 Feb;189(1):57-63. doi: 10.1007/s00408-010-9268-x.

PMID:
21107593
15.

Maspin expression and its clinical significance in non-small cell lung cancer.

Nakagawa M, Katakura H, Adachi M, Takenaka K, Yanagihara K, Otake Y, Wada H, Tanaka F.

Ann Surg Oncol. 2006 Nov;13(11):1517-23.

PMID:
17009165
16.

Expression of maspin in non-small-cell lung cancer: correlation with clinical features.

Takanami I, Abiko T, Koizumi S.

Clin Lung Cancer. 2008 Nov;9(6):361-6. doi: 10.3816/CLC.2008.n.052.

PMID:
19073519
17.

Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.

Varun BR, Ranganathan K, Rao UK, Joshua E.

J Investig Clin Dent. 2014 Aug;5(3):214-9. doi: 10.1111/jicd.12038.

PMID:
23776093
18.

p53 and bcl-2 protein expression in non-small-cell lung carcinoma.

Athanassiadou P, Dosios T, Petrakakou E, Liossi A, Zerva C, Athanassiades P.

Diagn Cytopathol. 1998 Oct;19(4):255-9.

PMID:
9784987
19.

P63 expression in lung carcinoma: a tissue microarray study of 408 cases.

Au NH, Gown AM, Cheang M, Huntsman D, Yorida E, Elliott WM, Flint J, English J, Gilks CB, Grimes HL.

Appl Immunohistochem Mol Morphol. 2004 Sep;12(3):240-7.

PMID:
15551738
20.

The use of p63 as an effective immunomarker in the diagnosis of pulmonary squamous cell carcinomas on de-stained bronchial lavage cytological smears.

Uke M, Rekhi B, Ajit D, Jambhekar NA.

Cytopathology. 2010 Feb;21(1):56-63. doi: 10.1111/j.1365-2303.2009.00678.x.

PMID:
19744186
Items per page

Supplemental Content

Support Center